KCM
CDMO

Karp Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Karp Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-286
Closed -$2K – 294
2015
Q3 		$2K Hold
286
– – ﹤0.01% 332
2015
Q2 		$3K Hold
286
– – ﹤0.01% 346
2015
Q1 		$3K Hold
286
– – ﹤0.01% 325
2014
Q4 		$3K Buy
+286
New +$2.88K ﹤0.01% 324

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Karp Capital Management's CDMO Position: Q4 2015 in Review

Karp Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2015, closing a stake of 286 shares — an estimated $2K sold.

Karp Capital Management first reported a position in CDMO in Q4 2014 and held it in 4 quarters. The position peaked at $3K in Q2 2015. 93 funds tracked by Wall St. Rank hold CDMO as of Q4 2015.

  • Karp Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Karp Capital Management sold 286 Avid Bioservices, Inc. Common Stock shares in Q4 2015, an estimated $2K.
  • Karp Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • Karp Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $3K in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2015.

Based on Karp Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.